Does pirenzepine suppress the undesirable effects of a proton pump inhibitor on enterochromaffin-like cells?
Shinomura
Y
Y
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D019861:Enterochromaffin-like Cells / Q000187:drug effects*; D004815:Epidermal Growth Factor / Q000096:biosynthesis / Q000187:drug effects; D005755:Gastrins / Q000187:drug effects / Q000378:metabolism; D006632:Histamine / Q000097:blood; D006801:Humans; D008297:Male; D010295:Parietal Cells, Gastric / Q000187:drug effects / Q000378:metabolism; D010890:Pirenzepine / Q000494:pharmacology*; D054328:Proton Pump Inhibitors; D012333:RNA, Messenger / Q000187:drug effects; D051381:Rats; D013270:Stomach / Q000737:chemistry* / Q000187:drug effects*
D000897:Anti-Ulcer Agents; D005755:Gastrins; D054328:Proton Pump Inhibitors; D012333:RNA, Messenger; D010890:Pirenzepine; D004815:Epidermal Growth Factor; D006632:Histamine